<?xml version='1.0' encoding='utf-8'?>
<document id="16019953"><sentence text="Assessment of the hepatic and intestinal first-pass metabolism of midazolam in a CYP3A drug-drug interaction model rats."><entity charOffset="66-75" id="DDI-PubMed.16019953.s1.e0" text="midazolam" /></sentence><sentence text="In the current study, to understand the characteristics of dexamethasone (DEX)-treated female rats as an animal model for drug-drug interactions, a double-cannulation method was applied and separately assessed for the intestinal and hepatic first-pass metabolism of midazolam"><entity charOffset="59-72" id="DDI-PubMed.16019953.s2.e0" text="dexamethasone" /></sentence><sentence text=" Midazolam was administered intravenously or orally to the animals, and midazolam concentrations in the portal and systemic plasma were simultaneously determined"><entity charOffset="1-10" id="DDI-PubMed.16019953.s3.e0" text="Midazolam" /><entity charOffset="72-81" id="DDI-PubMed.16019953.s3.e1" text="midazolam" /><pair ddi="false" e1="DDI-PubMed.16019953.s3.e0" e2="DDI-PubMed.16019953.s3.e0" /><pair ddi="false" e1="DDI-PubMed.16019953.s3.e0" e2="DDI-PubMed.16019953.s3.e1" /></sentence><sentence text=" Next, the rates of elimination from the intestine and liver were estimated using the AUC values" /><sentence text=" After oral administration of midazolam, the entire drug was absorbed without intestinal first-pass metabolism, and 93% of the administered midazolam was extracted in the liver of the DEX-treated female rats"><entity charOffset="30-39" id="DDI-PubMed.16019953.s5.e0" text="midazolam" /><entity charOffset="140-149" id="DDI-PubMed.16019953.s5.e1" text="midazolam" /><pair ddi="false" e1="DDI-PubMed.16019953.s5.e0" e2="DDI-PubMed.16019953.s5.e0" /><pair ddi="false" e1="DDI-PubMed.16019953.s5.e0" e2="DDI-PubMed.16019953.s5.e1" /></sentence><sentence text=" Seven per cent of the midazolam administered reached the systemic circulation"><entity charOffset="23-32" id="DDI-PubMed.16019953.s6.e0" text="midazolam" /></sentence><sentence text=" When ketoconazole was given orally to the animals, in conjunction with midazolam, the extraction ratio in the liver decreased from 93% to 77% in the control rats, and the bioavailability of midazolam increased to 23%"><entity charOffset="6-18" id="DDI-PubMed.16019953.s7.e0" text="ketoconazole" /><entity charOffset="72-81" id="DDI-PubMed.16019953.s7.e1" text="midazolam" /><entity charOffset="191-200" id="DDI-PubMed.16019953.s7.e2" text="midazolam" /><pair ddi="false" e1="DDI-PubMed.16019953.s7.e0" e2="DDI-PubMed.16019953.s7.e0" /><pair ddi="false" e1="DDI-PubMed.16019953.s7.e0" e2="DDI-PubMed.16019953.s7.e1" /><pair ddi="false" e1="DDI-PubMed.16019953.s7.e0" e2="DDI-PubMed.16019953.s7.e2" /><pair ddi="false" e1="DDI-PubMed.16019953.s7.e1" e2="DDI-PubMed.16019953.s7.e1" /><pair ddi="false" e1="DDI-PubMed.16019953.s7.e1" e2="DDI-PubMed.16019953.s7.e2" /></sentence><sentence text=" On the other hand, after intravenous administration, the elimination half-life of midazolam was not changed by ketoconazole pretreatment"><entity charOffset="83-92" id="DDI-PubMed.16019953.s8.e0" text="midazolam" /><entity charOffset="112-124" id="DDI-PubMed.16019953.s8.e1" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.16019953.s8.e0" e2="DDI-PubMed.16019953.s8.e0" /><pair ddi="false" e1="DDI-PubMed.16019953.s8.e0" e2="DDI-PubMed.16019953.s8.e1" /></sentence><sentence text=" These results indicated that midazolam is only extracted in the liver of DEX-treated female rats and that ketoconazole inhibits the hepatic first-pass metabolism, but not the systemic metabolism"><entity charOffset="30-39" id="DDI-PubMed.16019953.s9.e0" text="midazolam" /><entity charOffset="107-119" id="DDI-PubMed.16019953.s9.e1" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.16019953.s9.e0" e2="DDI-PubMed.16019953.s9.e0" /><pair ddi="false" e1="DDI-PubMed.16019953.s9.e0" e2="DDI-PubMed.16019953.s9.e1" /></sentence><sentence text=" In conclusion, DEX-treated female rats can be used as a drug-drug interaction model via CYP3A4 enzyme inhibition, especially for the hepatic first-pass metabolism of orally administered drugs" /><sentence text="" /></document>